| Literature DB >> 27154634 |
Michał Pędziwiatr1,2, Magdalena Pisarska3,4, Michał Kisielewski3,4, Piotr Major3,4, Anna Mydlowska3,4, Mateusz Rubinkiewicz3,4, Marek Winiarski3,4, Andrzej Budzyński3,4.
Abstract
Most of the studies concerning enhanced recovery after surgery (ERAS) protocols in colorectal surgery include heterogeneous groups of patients undergoing open or laparoscopic surgery, both due to colonic and rectal cancer, thus creating a potential bias. The data investigating the differences between patients operated for either colonic or rectal cancer are sparse. The aim of the study was to compare short-term outcomes of laparoscopic surgery for colonic and rectal cancer with ERAS protocol. The analysis included consecutive prospectively registered patients operated for a colorectal cancer between January 2012 and September 2015. Patients were divided into two groups (colon vs. rectum). The measured outcomes were: length of stay (LOS), complication rate, readmission rate, compliance with ERAS protocol elements and recovery parameters (tolerance of early oral diet, mobilization and time to first flatus). Group 1 (colon) consisted of 150 patients and Group 2 (rectum) of 82 patients. Patients in Group 1 (150 patients) were discharged home earlier than in Group 2 (82 patients)-median LOS 4 versus 5 days, respectively. There was no statistical difference in complication rate (27.3 vs. 36.6 %) and readmissions (7.3 vs. 6.1 %). Compliance with the protocol was 86.9 and 82.6 %, respectively. However, in Group 1, the following procedures were used less frequently: bowel preparation (24 vs. 78.3 %) and postoperative drainage (23.3 vs. 71.0 %). There were no differences in recovery parameters between the groups. Univariate logistic regression showed that the type of surgery, drainage and stoma creation significantly prolonged LOS. In a multivariate logistic regression model, only a bowel preparation and drainage were shown to be significant. Although functional recovery and high compliance with ERAS protocol are possible irrespective of the type of surgery, laparoscopic rectal resections are associated with a longer LOS.Entities:
Keywords: Colorectal cancer; Enhanced recovery after surgery; Fast-track surgery; Laparoscopy; Length of stay; Postoperative recovery
Mesh:
Year: 2016 PMID: 27154634 PMCID: PMC4859853 DOI: 10.1007/s12032-016-0772-6
Source DB: PubMed Journal: Med Oncol ISSN: 1357-0560 Impact factor: 3.064
ERAS protocol used in our department
| 1. Preoperative counseling and patient’s education |
| 2. No bowel preparation (oral lavage in the case of low rectal resection with TME and defunctioning loop ileostomy) |
| 3. Preoperative carbohydrate loading (400 ml of Nutricia preOp® 2 h prior surgery) |
| 4. Antithrombotic prophylaxis (Clexane® 40 mg sc. starting in the evening prior surgery) |
| 5. Antibiotic prophylaxis (preoperative cefuroxime 1.5 g + metronidazole 0.5 g iv 30–60 min. prior surgery) |
| 6. Laparoscopic surgery |
| 7. Balanced intravenous fluid therapy (<2500 ml intravenous fluids during the day of surgery, <150 mmol sodium) |
| 8. No nasogastric tubes postoperatively |
| 9. No drains left routinely for colonic resections, one drain placed for <24 h in case of TME |
| 10. TAP block and standard anesthesia protocol |
| 11. Avoiding opioids, multimodal analgesia (oral when possible—paracetamol 4 × 1 g, ibuprofen 2 × 200 mg, metamizole 2 × 500 mg, or ketoprofen 2 × 100 mg) |
| 12. Prevention of postoperative nausea and vomiting (PONV) (dexamethasone 8 mg iv., ondansetron 8 mg iv., metoclopramide 10 mg iv.) |
| 13. Postoperative oxygenation therapy (4–6 l/min.) |
| 14. Early oral feeding (oral nutritional supplement 4 h postoperatively—Nutricia Nutridrink® or Nestlé Impact®, light hospital diet and oral nutritional supplements on the first postoperative day, full hospital diet in the second postoperative day) |
| 15. Urinary catheter removal on the first postoperative day |
| 16. Full mobilization on the first postoperative day (getting out of bed, going to toilette, walking along the corridor, at least 4 h out of bed) |
Fig. 1Patient flowchart
Demographic analysis of patient groups
| Parameter | Group 1 (colon) | Group 2 (rectum) |
|
|---|---|---|---|
| Number of patients (n) | 150 (64.7 %) | 82 (35.3 %) | – |
| Females [n (%)] | 78 (52.0 %) | 28 (34.1 %) | 0.0086 |
| Males [n (%)] | 72 (48.0 %) | 54 (65.9 %) | |
| Mean age (years ± SD) | 67.7 ± 13.2 | 64.1 ± 10.3 | 0.0069 |
| BMI (kg/m2 ± SD) | 26.0 ± 5.1 | 26.8. ± 4.8 | 0.1489 |
| ASA 1 [n (%)] | 3 (2.0 %) | 2 (2.4 %) | 0.1903 |
| ASA 2 [n (%)] | 90 (60.0 %) | 58 (70.7 %) | |
| ASA 3 [n (%)] | 52 (34.7 %) | 22 (26.9 %) | |
| ASA 4 [n (%)] | 5 (3.3 %) | – | |
| AJCC stage I [n (%)] | 47 (31.3 %) | 30 (36.6 %) | 0.2603 |
| AJCC stage II [n (%)] | 43 (28.7 %) | 27 (32.9 %) | |
| AJCC stage III [n (%)] | 43 (28.7 %) | 14 (17.1 %) | |
| AJCC stage IV [n (%)] | 17 (11.3 %) | 11 (13.4 %) | |
| Right hemicolectomy [n (%)] | 81 (54.0 %) | – | – |
| Left hemicolectomy [n (%)] | 13 (8.7 %) | – | |
| Sigmoid resection [n (%)] | 54 (36.0 %) | – | |
| Hartmann’s operation [n (%)] | 2 (1.3 %) | – | |
| Low anterior resection of the rectum [n (%)] | – | 76 (92.7 %) | |
| Abdominoperineal excision [n (%)] | – | 6 (7.3 %) | |
| Formation of stoma | 5 (3.3 %) | 41 (50.0 %) | <0.0001 |
| Colostomy | 5 (3.3 %) | 9 (11.0 %) | |
| Ileostomy | – | 32 (39.0 %) | |
| Mean operative time (min. ± SD) | 186.7 ± 57.7 | 200.5 ± 64.5 | 0.1080 |
| Median operative time [min.(IQR)] | 180 (140–212.5) | 200 (150–240) | |
| Mean intraoperative blood loss (ml ± SD) | 96.8 ± 83.3 | 110.7 ± 96.3 | 0.2640 |
| Median intraoperative blood loss [ml (IQR)] | 70 (50–150) | 100 (50–150) | |
| Conversion [n (%)] | 7 (4.7 %) | 3 (3.7 %) | 0.7145 |
Fig. 2Percentage of patients based on the length of stay in hospital depending on the type of surgery
Types of complications according to Clavien–Dindo classification
| Clavien–Dindo classification | Complications | Group 1 (colon) | Group 2 (rectum) |
| ||
|---|---|---|---|---|---|---|
| V | Death (anastomotic leakage, reoperation, myocardial infarction during relaparotomy) | 1 | 1 (0.7 %) | 0 | – | 0.5834 |
| IV | Anastomotic leakage (ICU stay) | 1 | 1 (0.7 %) | 0 | – | |
| III B | Anastomotic leakage | 2 | 7 (4.7 %) | 1 | 8 (9.7 %) | |
| Perforation of transverse colon from Veress needle | 0 | 1 | ||||
| Perforation of small intestine | 1 | 0 | ||||
| Peristomal fistula | 0 | 1 | ||||
| Stoma necrosis | 0 | 1 | ||||
| Trocar-related abdominal wall bleeding | 1 | 0 | ||||
| Postoperative paralytic ileus | 0 | 1 | ||||
| Cholecystitis | 1 | 0 | ||||
| III A | Anastomosis leakage (managed with Endo-SPONGE®) | 0 | 3 | |||
| Bleeding from anastomotic suture line (controlled endoscopically) | 2 | 0 | ||||
| II | Anastomotic leakage (confirmed in CT, managed conservatively) | 1 | 7 (4.7 %) | 0 | 3 (3.6 %) | |
| Intraperitoneal hematoma | 0 | 1 | ||||
| Urinary tract infection | 2 | 1 | ||||
| Infectious diarrhea (C. difficile) | 1 | 0 | ||||
| Pneumonia | 1 | 0 | ||||
| Fever of unknown origin | 1 | 0 | ||||
| Urinary retention | 1 | 0 | ||||
| Perineal abscess after APR | 0 | 1 | ||||
| I | Surgical site infection | 7 | 25 (16.7 %) | 4 | 19 (23.2 %) | |
| Postoperative nausea and vomiting | 7 | 4 | ||||
| Non-infectious diarrhea | 2 | 1 | ||||
| Postoperative paralytic ileus (managed conservatively) | 2 | 5 | ||||
| High-output stoma | 0 | 3 | ||||
| Bleeding from anastomosis suture line | 2 | 1 | ||||
| Surgical site hematoma | 3 | 1 | ||||
| Arrhythmia | 1 | 0 | ||||
| Postoperative confusion | 1 | 0 | ||||
Fig. 3Compliance with perioperative elements of ERAS protocol in both groups. Statistically significant differences between the groups are marked with an asterisk. Note: In the case of MBP, the chart presents the actual percentage of patients receiving no MBP, not the compliance with the protocol (no MBP in the case of colonic surgery, oral bowel preparation in the case of LAR with ileostomy)
Uni- and multivariate logistic regression analysis of the parameters prolonging length of stay
| Parameter | Univariate logistic regression | Multivariate logistic regression | ||||
|---|---|---|---|---|---|---|
| OR | 95 % CI |
| OR | 95 % CI |
| |
| Age (>65 vs. ≤65 years) | 1.37 | 0.80–2.34 |
|
| ||
| Sex (male vs. female) | 1.66 | 0.98–2.83 |
| – | ||
| BMI (>25 kg/m2 vs. ≤25 kg/m2) | 1.04 | 0.67–1.62 |
| – | ||
| ASA grade (4–1) | 1.06 | 0.67–1.67 |
| – | ||
| AJCC stage (IV—I) | 1.09 | 0.85–1.41 |
| – | ||
| Mechanical bowel preparation (yes vs. no) | 2.81 | 1.63–4.86 |
| 2.24 | 1.19–4.20 |
|
| Peritoneal drainage (yes vs. no) | 3.42 | 1.95–5.99 |
| 2.85 | 1.54–5.28 |
|
| Stoma formation (yes vs. no) | 2.70 | 1.38–5.28 |
| 1.54 | 0.65–3.63 |
|
| Rectum/colon | 1.89 | 1.10–3.27 |
| 1.34 | 0.63–2.85 |
|